LIGHT CHAIN ANALYSIS INCREASED

This adverse event was reported 496 times

These drugs are most commonly taken by patients reporting LIGHT CHAIN ANALYSIS INCREASED:

# Drug Count
0 DEXAMETHASONE 171
1 DEXAMETHASONE 1.5 MG 164
2 LENALIDOMIDE 139
3 BORTEZOMIB 86
4 POMALIDOMIDE 58
5 ACYCLOVIR 57
6 ACYCLOVIR SODIUM 52
7 CARFILZOMIB 49
8 ASPIRIN 44
9 ASPIRIN 325 MG 41
See all common drugs associated with LIGHT CHAIN ANALYSIS INCREASED

LIGHT CHAIN ANALYSIS INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FERROUS ASPARTO GLYCINATE, FERROUS FUMARATE, ASCORBIC ACID, FOLIC ACID, CYANOCOBALAMIN, ZINC, AND INTRINSIC FACTOR 2 0.0220
1 ROLAPITANT 1 0.0088
2 SILVER NITRATE 1 0.0085
3 CARBAMIDE PEROXIDE 1 0.0047
4 DARATUMUMAB 31 0.0045
5 CUPRIC CHLORIDE 1 0.0036
6 CARFILZOMIB 49 0.0035
7 IXAZOMIB 31 0.0033
8 OMEPRAZOLE, SODIUM BICARBONATE 1 0.0032
9 EPOETIN ALFA-EPBX 1 0.0031
See all drugs enriched for association with LIGHT CHAIN ANALYSIS INCREASED

LIGHT CHAIN ANALYSIS INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Tetracycline-class Drug [EPC] 4 0.0001
1 Stimulant Laxative [EPC] 1 0.0001
2 Angiotensin Converting Enzyme Inhibitor [EPC] 6 0.0001
3 Purine Antimetabolite [EPC] 2 0.0001
4 Insulin Analog [EPC] 6 0.0000
See all drug classes enriched for association with LIGHT CHAIN ANALYSIS INCREASED